Home - Products - Angiogenesis - PDE - Autotaxin-IN-3

Autotaxin-IN-3

CAS No. 2156655-68-2

Autotaxin-IN-3( —— )

Catalog No. M26066 CAS No. 2156655-68-2

Autotaxin-IN-3 is an Autotaxin(ATX) inhibitor (IC50: 2.4 nM) sourced from patent WO2018212534A1 (compound 33).

Purity : >98% (HPLC)

COA

Datasheet

HNMR

HPLC

MSDS

Handing Instructions

Size	Price / USD	Stock	Quantity
2MG	97	Get Quote
5MG	160	Get Quote
10MG	260	Get Quote
25MG	484	Get Quote
50MG	745	Get Quote
100MG	1197	Get Quote
500MG	2394	Get Quote
1G	Get Quote	Get Quote

Get Quotation Bulk Inquiry Add to Cart

Biological Information

Product Name

Autotaxin-IN-3
Note

Research use only, not for human use.
Brief Description

Autotaxin-IN-3 is an Autotaxin(ATX) inhibitor (IC50: 2.4 nM) sourced from patent WO2018212534A1 (compound 33).
Description

Autotaxin-IN-3 is an Autotaxin(ATX) inhibitor (IC50: 2.4 nM) sourced from patent WO2018212534A1 (compound 33).
In Vitro

Autotaxin is an enzyme which is responsible for the increase in lysophosphatidic acid in ascites and plasma, and it is a secretory enzyme important for converting lysophosphatidylchloine (LPC) into lysophosphatidic acid (LPA) as a bioactive signaling molecule.
In Vivo

——
Synonyms

——
Pathway

Angiogenesis
Target

PDE
Recptor

——
Research Area

——
Indication

——

Chemical Information

CAS Number

2156655-68-2
Formula Weight

443.471
Molecular Formula

C22H21N9O2
Purity

>98% (HPLC)
Solubility

In Vitro:?DMSO : 250 mg/mL (563.75 mM)
SMILES

O=C(Cc1nnc(o1)-c1cnc(NC2Cc3ccccc3C2)nc1)N1CCc2nn[nH]c2C1
Chemical Name

——

Shipping & Storage Information

Storage

(-20℃)
Shipping

With Ice Pack
Stability

≥ 2 years

Reference

Calculator

Molecular Weight Calculator

Dilution Calculator

Molarity Calculator

molnova catalog

related products

Apremilast

Apremilast (CC-10004) is a potent, orally active PDE4 inhibitor with IC50 of 74 nM, inhibits TNF-α production in LPS-stimulated hPBMCs with IC50 of 77 nM.
CI-1044

CI-1044 is a potent, selective and orally bioavailable PDE4 inhibitor with IC50 of 0.27 uM.
CRT0273750

CRT0273750 regulates plasma LPA levels and is suitable for in vivo studies. CRT0273750 is an autotaxin (ATX) inhibitor with IC50 of 0.014 μM.

Sign In Join Free